Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.
第一作者:
Sarah,Kraus
第一单位:
Integrated Cancer Prevention Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
作者:
主题词
腺瘤(Adenoma);腺瘤性息肉(Adenomatous Polyps);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);心血管疾病(Cardiovascular Diseases);结直肠肿瘤(Colorectal Neoplasms);环氧化酶2抑制剂(Cyclooxygenase 2 Inhibitors);女(雌)性(Female);胃肠疾病(Gastrointestinal Diseases);遗传变异(Genetic Variation);人类(Humans);炎症(Inflammation);连锁不平衡(Linkage Disequilibrium);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);遗传药理学(Pharmacogenetics);试点项目(Pilot Projects);多态性, 单核苷酸(Polymorphism, Single Nucleotide);吡唑类(Pyrazoles);磺胺类(Sulfonamides)
DOI
10.1097/FPC.0b013e3283631784
PMID
23778325
发布时间
2021-10-21
- 浏览14

Pharmacogenetics and genomics
428-437页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文